Literature DB >> 5775342

A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques.

D S Fredrickson, R I Levy, F T Lindgren.   

Abstract

Eight plasma lipoprotein patterns currently employed in attempts to identify different forms of familial dyslipoproteinemia have been compared by two methods. The first (NIH method) is based on paper electrophoretic patterns produced by the four lipoprotein classes obtained by paper electrophoresis in albuminated buffer, coupled with the measurement of the total cholesterol of three of these lipoprotein classes and ascertainment of abnormal flotation of beta-migrating lipoproteins. The second (Donner method) is based on lipoprotein patterns obtained in the analytical ultracentrifuge, adapted for computer analysis and complemented by chemical determination of the concentration of chylomicrons (lipoproteins of S(f) degrees > 400). Pooled samples representing patients with five types of familial hyperlipoproteinemia and three different forms of inherited lipoprotein dificiency were separately analyzed. For six of the eight pools, both methods provided a distinctive lipoprotein pattern in terms of changes in one or more variables. For the remaining two pools, type IV hyperlipoproteinemia and the heterozygote for Tangier disease, both methods provided identical but not unique patterns. The results indicate that lipoprotein analyses obtained by either method may be used interconvertibly in further genetic and other clinical studies.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5775342      PMCID: PMC297410          DOI: 10.1172/JCI105927

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer.

Authors:  R S LEES; F T HATCH
Journal:  J Lab Clin Med       Date:  1963-03

2.  Idiopathic hyperlipemia: metabolic studies in an affected family.

Authors:  R J HAVEL; R S GORDON
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

3.  Familial hypercholesteremic xanthomatosis: a preliminary report. I. Clinical, electrocardiographic and laboratory considerations.

Authors:  J L GURAVICH
Journal:  Am J Med       Date:  1959-01       Impact factor: 4.965

4.  [On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins].

Authors:  M BURSTEIN; J SAMAILLE
Journal:  Clin Chim Acta       Date:  1960-07       Impact factor: 3.786

5.  Ultracentrifugal analysis of serum lipoproteins.

Authors:  O F DE LALLA; J W GOFMAN
Journal:  Methods Biochem Anal       Date:  1954

6.  Lipoproteins and xanthomatous diseases.

Authors:  J McGINLEY; H JONES; J GOFMAN
Journal:  J Invest Dermatol       Date:  1952-07       Impact factor: 8.551

7.  Ultracentrifugal isolation of serum chylomicron-containing fractions with quantitation by infrared spectrometry and NCH elemental analysis.

Authors:  F T Hatch; N K Freeman; L C Jensen; G R Stevens; F T Lindgren
Journal:  Lipids       Date:  1967-03       Impact factor: 1.880

8.  The lipoproteins and lipid transport in abetalipoproteinemia.

Authors:  R I Levy; D S Fredrickson; L Laster
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

9.  The differentiation of exogenous and endogenous hyperlipemia by paper electrophoresis.

Authors:  R S Lees; D S Fredrickson
Journal:  J Clin Invest       Date:  1965-12       Impact factor: 14.808

10.  Abnormalities of high density lipoproteins in abetalipoproteinemia.

Authors:  J W Jones; P Ways
Journal:  J Clin Invest       Date:  1967-07       Impact factor: 14.808

View more
  33 in total

1.  Quantitation of high density lipoproteins.

Authors:  J J Albers; G R Warnick; M C Chenng
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

2.  Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro.

Authors:  J R Patsch; A M Gotto; T Olivercrona; S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

3.  The pathology of Tangier disease. A light and electron microscopic study.

Authors:  V J Ferrans; D S Fredrickson
Journal:  Am J Pathol       Date:  1975-01       Impact factor: 4.307

4.  Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha 2-macroglobulin-recognition site.

Authors:  M C van Dijk; G J Ziere; W Boers; C Linthorst; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

5.  Bivariate analyses of cholesterol and triglyceride levels in families in which probands have type IIb lipoprotein phenotype.

Authors:  K K Namboodiri; R C Elston; C J Glueck; R Fallat; C R Buncher; R Tsang
Journal:  Am J Hum Genet       Date:  1975-07       Impact factor: 11.025

6.  A comparison of simplified methods for lipoprotein quantification using the analytic ultracentrifuge as a standard.

Authors:  F T Lindgren; A Silvers; R Jutaglr; L Layshot; D D Bradley
Journal:  Lipids       Date:  1977-03       Impact factor: 1.880

7.  Properties of the plasma very low and low density lipoproteins in Tangier disease.

Authors:  R J Heinen; P N Herbert; D S Fredrickson
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

8.  Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein.

Authors:  S E Lux; R I Levy; A M Gotto; D S Fredrickson
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  Kinetics of insulin secretion following glucose infusion in patients with atherosclerotic peripheral vascular disease.

Authors:  C R Sirtori; G Biasi; E Malan; L Meciani; M Sirtori; E Cerasi
Journal:  Acta Diabetol Lat       Date:  1979 Apr-Jun

10.  Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

Authors:  S Eisenberg; D Gavish; Y Oschry; M Fainaru; R J Deckelbaum
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.